BusinessMyriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's PARP Inhibitor, OlaparibBy Nasdaq OMXFeb 17, 2017, 12:30 PM UTC
BusinessMyriad’s Prolaris® Test Significantly Improves the Risk Classification for One Third of Men Diagnosed with Localized Prostate CancerBy Nasdaq OMXFeb 17, 2017, 12:05 PM UTC
BusinessEarth Science Tech, Inc. Enters $60B Pet Industry with its Nutraceutical Scientific High Grade Hemp CBD Oil Intended for Domestic AnimalsBy Nasdaq OMXFeb 16, 2017, 12:15 PM UTC
BusinessData Presented at CROI Show CytoDyn’s Pro 140 as a Single Agent Provided Maximal Virologic Suppression in HIV Patients for Nearly Two YearsBy Nasdaq OMXFeb 16, 2017, 12:00 AM UTC
BusinessNew Arizona Tech Company, IONaer, Redefines the Standard For Indoor Air QualityBy Nasdaq OMXFeb 15, 2017, 2:07 PM UTC
BusinessPurdue-affiliated pharmaceutical company launches product to produce rare disease-fighting compoundsBy Nasdaq OMXFeb 15, 2017, 1:15 PM UTC
Businessathenahealth’s Health Plan Data Exchange Service Enables Data Exchange Between Providers and Health PlansBy Nasdaq OMXFeb 15, 2017, 1:01 PM UTC
Businessathenahealth’s Health Plan Data Exchange Service Enables Data Exchange Between Providers and Health PlansBy Nasdaq OMXFeb 15, 2017, 1:01 PM UTC
